← Back to Clinical Trials
Recruiting NCT06793800

NCT06793800 Effect of Transcutaneous Auricular Vagus Nerve Stimulation Application on Respiratory Functions in Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06793800
Status Recruiting
Phase
Sponsor Fenerbahce University
Condition Hemiplegia
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-08-05
Primary Completion 2025-08-26

Trial Parameters

Condition Hemiplegia
Sponsor Fenerbahce University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 40 Years
Max Age 80 Years
Start Date 2025-08-05
Completion 2025-08-26
Interventions
Transcutaneous Auricular Vagus Nerve Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to evaluate the effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation (TAVSS) in improving respiratory muscle strength and function in chronic stroke patients. It aims to explore TAVSS as a potential complementary approach in enhancing rehabilitation outcomes for this population.

Eligibility Criteria

Inclusion Criteria: * Being a chronic stroke patient with an ischemic or hemorrhagic stroke diagnosis made 1-3 years ago * Having been diagnosed with stroke for the first time * Ability to understand and follow simple verbal instructions * Being between the ages of 40 and 80 * No conditions affecting perioral muscles, such as facial paralysis or swallowing disorders * No visual, auditory, or communication problems * No cardiopulmonary disorders * No additional neurological, cardiovascular, orthopedic, or similar conditions causing balance problems * Mini Mental State Examination (MMSE) score ≥24 * No surgical operations or Botox applications in the last 6 months * Scoring 2 or below on the Modified Ashworth Scale Exclusion Criteria: * Presence of infection, ulcer, or scar on the auricle * Metallic implants in the skull, hypersensitivity, injury, or inflammation inside the ear * Chronic pulmonary and/or cardiac diseases * Resting heart rate below 60 beats per minute * Devices such as pa

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology